St. Gallen breast cancer risk category for relapse includes her2

[RobinP]

The new 2005 St. Gallen guidelines for breast cancer staging include her2 as a prognostic index as opposed to ignoring it like the Nothamington Prognostic index and other guildlines. It's about time her2 is not ignored as a increased risk factor for relapse. All her2s are either at intermediate or high risk according to the new 2005 St. Gallen standards.Two new prognostic features are included in the updated 2005 St. Gallen's standards.The first was over-expession or amplification of the HER2/neu gene, and the second was peritumoural vessel invasion, especially lymphovascular invasion.

http://www.breastcancersource.com/br...596_7_0_0.aspx